You are now visiting tipharma.com.
On 1 January, 2016, TI Pharma and CTMM merged
to form a new organization called Lygature.
Please note that information on the tipharma.com site has not
been updated since, and is retained as an archive.
For up-to-date information, please visit lygature.org.
Mondriaan: a Dutch 'population' laboratory
A lot of excellent scientific knowledge exists in several databases in the Dutch health care and research institutes. This project aims to connect all this knowledge and make it available to researchers in order to fuel pharmaceutical research in the Netherlands and to play an internationally competitive role in drug intelligence and innovation.
Scientific integrity is one of the foremost factors of the database. Therefore, a system was developed that couples data in an anonymous way, and all research requests are screened for relevance and validity. Furthermore, a structure was designed to enable best scientific use of the data both for academic and industrial researchers. The next step in the project is to create a legal and financial basis for long term continuation of Mondriaan as an institute with national and international impact.
Full project title: The Mondriaan
Project: The Dutch healthcare landscape as a 'population laboratory'
Start date: June 2007
End date: June 2013
Goal: Create a national data network containing healthcare and research databases to fuel pharmaceutical research in the Netherlands
Principal investigator: Rick Grobbee
Project size: 9 FTE's
Partners: GlaxoSmithKline, Sanofi Aventis, University Medical Center Utrecht, University Medical Center Groningen, University of Groningen, Utrecht University
“Running public-private partnerships is a profession by itself. TI Pharma is an excellent example of how you can do this in an effective way.”
Director/Secretary of the Medicines Evaluation Board